Literature DB >> 18155315

Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides.

Bryan R Meade1, Steven F Dowdy.   

Abstract

The major limitation in utilizing information rich macromolecules for basic science and therapeutic applications is the inability of these large molecules to readily diffuse across the cellular membrane. While this restriction represents an efficient defense system against cellular penetration of unwanted foreign molecules and thus a crucial component of cell survival, overcoming this cellular characteristic for the intracellular delivery of macromolecules has been the focus of a large number of research groups worldwide. Recently, with the discovery of RNA interference, many of these groups have redirected their attention and have applied previously characterized cell delivery methodologies to synthetic short interfering RNA duplexes (siRNA). Protein transduction domain and cell penetrating peptides have been shown to enhance the delivery of multiple types of macromolecular cargo including peptides, proteins and antisense oligonucleotides and are now being utilized to enhance the cellular uptake of siRNA molecules. The dense cationic charge of these peptides that is critical for interaction with cell membrane components prior to internalization has also been shown to readily package siRNA molecules into stable nanoparticles that are capable of traversing the cell membrane. This review discusses the recent advances in noncovalent packaging of siRNA molecules with cationic peptides and the potential for the resulting complexes to successfully induce RNA interference within both in vitro and in vivo settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155315      PMCID: PMC2293332          DOI: 10.1016/j.addr.2007.10.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  41 in total

1.  Is VP22 nuclear homing an artifact?

Authors:  M Lundberg; M Johansson
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

2.  Cellular translocation of proteins by transportan.

Authors:  M Pooga; C Kut; M Kihlmark; M Hällbrink; S Fernaeus; R Raid; T Land; E Hallberg; T Bartfai; U Langel
Journal:  FASEB J       Date:  2001-06       Impact factor: 5.191

3.  Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.

Authors:  Jean Philippe Richard; Kamran Melikov; Eric Vives; Corinne Ramos; Birgit Verbeure; Mike J Gait; Leonid V Chernomordik; Bernard Lebleu
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

4.  Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells.

Authors:  Federica Simeoni; May C Morris; Frederic Heitz; Gilles Divita
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

5.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.

Authors:  Aleksandra Muratovska; Michael R Eccles
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

6.  Cell surface adherence and endocytosis of protein transduction domains.

Authors:  Mathias Lundberg; Sara Wikström; Magnus Johansson
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

7.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

8.  Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.

Authors:  S Futaki; T Suzuki; W Ohashi; T Yagami; S Tanaka; K Ueda; Y Sugiura
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

9.  Cationic liposome-mediated delivery of siRNAs in adult mice.

Authors:  Mouldy Sioud; Dag R Sørensen
Journal:  Biochem Biophys Res Commun       Date:  2003-12-26       Impact factor: 3.575

10.  Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time.

Authors:  Aldo Ferrari; Vittorio Pellegrini; Caterina Arcangeli; Antonio Fittipaldi; Mauro Giacca; Fabio Beltram
Journal:  Mol Ther       Date:  2003-08       Impact factor: 11.454

View more
  54 in total

Review 1.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

2.  Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.

Authors:  Jennifer A MacDiarmid; Nancy B Amaro-Mugridge; Jocelyn Madrid-Weiss; Ilya Sedliarou; Stefanie Wetzel; Kartini Kochar; Vatsala N Brahmbhatt; Leo Phillips; Scott T Pattison; Carlotta Petti; Bruce Stillman; Robert M Graham; Himanshu Brahmbhatt
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

3.  siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.

Authors:  Mark D Zabel; Luke Mollnow; Heather Bender
Journal:  Methods Mol Biol       Date:  2021

4.  Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.

Authors:  Martina Tuttolomondo; Henrik J Ditzel
Journal:  Methods Mol Biol       Date:  2021

5.  Lipopeptide Delivery of siRNA to the Central Nervous System.

Authors:  Mark D Zabel; Luke Mollnow; Heather Bender
Journal:  Methods Mol Biol       Date:  2019

6.  Functional Delivery of siRNA by Disulfide-Constrained Cyclic Amphipathic Peptides.

Authors:  Jade J Welch; Ria J Swanekamp; Christiaan King; David A Dean; Bradley L Nilsson
Journal:  ACS Med Chem Lett       Date:  2016-03-30       Impact factor: 4.345

7.  Melittin derived peptides for nanoparticle based siRNA transfection.

Authors:  Kirk K Hou; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

8.  Lipopeptide delivery of siRNA to the central nervous system.

Authors:  Mark D Zabel
Journal:  Methods Mol Biol       Date:  2013

9.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.